Gland Pharma Shares Fall on Fears of Undervalued Sale by Chinese Owner
Shares of Gland Pharma continued to fall on October 31, down 23% overall in three sessions, dealers said, amid concerns over a possible stake sale...
Download Unicorn Signals App
Powered By EquityPandit
